Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210996) titled 'A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Proportions in Healthy Subjects' on Sept. 30.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Abbisko Therapeutics Co, Ltd
Condition:
Pharmacokinetics in Healthy Volunteers
Intervention:
Drug: pimicotinib capsules
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 12, 2025
Target Sample Size: 20
Countries of Recruitment:
China
To know m...